{
    "title": "Regeneron says its COVID-19 antibody treatment cut medical visits in trial",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8890683/Regeneron-says-COVID-19-antibody-treatment-cut-medical-visits-trial.html",
    "date": "2020-10-28",
    "keywords": [
        "treatment",
        "covid19",
        "company",
        "regeneron",
        "month",
        "drug",
        "eua",
        "erman",
        "wednesday",
        "antibody",
        "trial",
        "cocktail",
        "therapy",
        "government",
        "coronavirus",
        "president",
        "regncov2",
        "placebo",
        "day",
        "period",
        "drop",
        "age",
        "obesity",
        "metabolic",
        "lung",
        "liver",
        "disease",
        "status",
        "immune",
        "system",
        "recovery",
        "emergency",
        "use",
        "authorization",
        "cost",
        "food",
        "administration",
        "dualantibody",
        "regulator",
        "part",
        "review",
        "request",
        "eli",
        "contract",
        "ready",
        "distribution",
        "june",
        "reporting",
        "adler",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}